Purposeful penalization of likelihood in small samples

エピソード

Penalization Theory and Practice for Cox Models
18 4月 2019· ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
ISCB 2013
- 見るもう一度見る続ける視聴中...
- 後で見る後で見る
Biomarker-based phase III clinical trial: Real-world experiences
18 4月 2019· ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
ISCB 2013
- 見るもう一度見る続ける視聴中...
- 後で見る後で見る
エピソードを見逃しましたか？

フィードを更新するにはここをクリックしてください。
Estimating effects of time-varying treatments: pitfalls and opportunities
18 4月 2019· ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
ISCB 2013
- 見るもう一度見る続ける視聴中...
- 後で見る後で見る
Evaluating and addressing consistency of the evidence in a network metaanalysis
18 4月 2019· ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
ISCB 2013
- 見るもう一度見る続ける視聴中...
- 後で見る後で見る
Recent developments in updating and extending risk prediction models, the European Randomized Study of Prostate Cancer Risk Calculator
18 4月 2019· ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
ISCB 2013
- 見るもう一度見る続ける視聴中...
- 後で見る後で見る
From model building to validation and back: a plea for robustness
18 4月 2019· ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
ISCB 2013
- 見るもう一度見る続ける視聴中...
- 後で見る後で見る
Using network meta-analysis for decision making
18 4月 2019· ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
ISCB 2013
- 見るもう一度見る続ける視聴中...
- 後で見る後で見る
Joint longitudinal survival models for prediction of prostate cancer recurrence following radiotherapy
18 4月 2019· ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
ISCB 2013
- 見るもう一度見る続ける視聴中...
- 後で見る後で見る
Adaptive designs for confirmatory clinical trials with treatment selection
18 4月 2019· ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
ISCB 2013
- 見るもう一度見る続ける視聴中...
- 後で見る後で見る
Recent developments in updating and extending risk prediction models, the Prostate Cancer Prevention Trial Calculator
29 8月 2013· ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
contribution and discussion
- 見るもう一度見る続ける視聴中...
- 後で見る後で見る
Gene signatures as treatment modifiers in clinical trial
29 8月 2013· ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
ISCB 2013
- 見るもう一度見る続ける視聴中...
- 後で見る後で見る
Biomarker-based phase II trial designs
29 8月 2013· ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
ISCB 2013
- 見るもう一度見る続ける視聴中...
- 後で見る後で見る
Utility-Based Dose-Finding with Ordinal Toxicity and Efficacy
29 8月 2013· ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
ISCB 2013
- 見るもう一度見る続ける視聴中...
- 後で見る後で見る
Causal search in high-dimensional settings
29 8月 2013· ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
ISCB 2013
- 見るもう一度見る続ける視聴中...
- 後で見る後で見る
Assessing mediation through multiple pathways using natural effect models
28 8月 2013· ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
ISCB 2013
- 見るもう一度見る続ける視聴中...
- 後で見る後で見る
The meta-analytic approach to validation of surrogate endpoints
28 8月 2013· ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
ISCB 2013
- 見るもう一度見る続ける視聴中...
- 後で見る後で見る
TBD (on meta-regression)
28 8月 2013· ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
ISCB 2013
- 見るもう一度見る続ける視聴中...
- 後で見る後で見る
Two folklores: ridge regression versus the lasso
27 8月 2013· ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
ISCB 2013
- 見るもう一度見る続ける視聴中...
- 後で見る後で見る
Purposeful penalization of likelihood in small samples
27 8月 2013· ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
ISCB 2013
- 見るもう一度見る続ける視聴中...
- 後で見る後で見る

エピソード

Penalization Theory and Practice for Cox Models

Biomarker-based phase III clinical trial: Real-world experiences

Estimating effects of time-varying treatments: pitfalls and opportunities

Evaluating and addressing consistency of the evidence in a network metaanalysis

Recent developments in updating and extending risk prediction models, the European Randomized Study of Prostate Cancer Risk Calculator

From model building to validation and back: a plea for robustness

Using network meta-analysis for decision making

Joint longitudinal survival models for prediction of prostate cancer recurrence following radiotherapy

Adaptive designs for confirmatory clinical trials with treatment selection

Recent developments in updating and extending risk prediction models, the Prostate Cancer Prevention Trial Calculator

Gene signatures as treatment modifiers in clinical trial

Biomarker-based phase II trial designs

Utility-Based Dose-Finding with Ordinal Toxicity and Efficacy

Causal search in high-dimensional settings

Assessing mediation through multiple pathways using natural effect models

The meta-analytic approach to validation of surrogate endpoints

TBD (on meta-regression)

Two folklores: ridge regression versus the lasso